The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
Abstract HER2 and HER3 play key driving functions in the pathophysiology of HER2-amplified breast cancers, but this function is less well characterized in other cancers driven by HER2 amplification. This study aimed to explore the role of HER2 and HER3 signaling in other types of HER2-amplified canc...
Saved in:
Main Authors: | Avisek Majumder, Manbir Sandhu, Debarko Banerji, Veronica Steri, Adam Olshen, Mark M. Moasser |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c397830c5fdc4bd9aad3949e664aac3c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
by: Stenehjem DD, et al.
Published: (2014) -
Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
by: Advani P, et al.
Published: (2015) -
Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
by: Yuefeng Wang, et al.
Published: (2017) -
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
by: Fara Brasó-Maristany, et al.
Published: (2020) -
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
by: Nindo B. Punturi, et al.
Published: (2021)